Silver Book Fact

Visual impairment and blindness cause an annual health utility loss of approximately $10.5 billion. This figure measures lost quality of life when a disease has little or no short-term impact on mortality.

Frick, Kevin D., Emily W. Gower, John H. Kempen, and Jennifer L. Wolff. Economic Impact of Visual Impairment and Blindness in the United States. Archives of Ophthalmology. 2007; 125(4): 544-50. http://archopht.ama-assn.org/cgi/content/abstract/125/4/544

Reference

Title
Economic Impact of Visual Impairment and Blindness in the United States
Publication
Archives of Ophthalmology
Publication Date
2007
Authors
Frick, Kevin D., Emily W. Gower, John H. Kempen, and Jennifer L. Wolff
Volume & Issue
Volume 125, Issue 4
Pages
544-50
URL
Read Full Resource

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • Age-related macular degeneration (AMD) is the leading cause of irreversible vision loss in people over the age of 65.  
  • Of the study participants in the Los Angeles Latino Eye Study (LALES) who had open-angle glaucoma, 75% were previously undiagnosed.  
  • The average cost in 2004 per glaucoma patient age 40 to 64 using outpatient services was $276. The average cost per patient 54 years and older was $254.  
  • The annual direct medical costs (including outpatient, inpatient, and prescription drug services) for Americans age 40 and older with age-related macular degeneration (AMD) is $575 million.  
  • Individuals who are visually impaired are less likely to be employed–44% are employed compared to 85% of adults with normal vision.